Citation

BibTex format

@inproceedings{Goritzka:2014,
author = {Goritzka, M and Durant, LR and Pereira, C and Salek-Ardakani, S and Openshaw, P and Johansson, C},
pages = {6128--6136},
publisher = {Wiley},
title = {Interferon-a/b  receptor signalling is amplifying early proinflammatory cytokine production in the lung during Respiratory Syncytial Virus (RSV) infection},
url = {http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000327487700209&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202},
year = {2014}
}
Download

RIS format (EndNote, RefMan)

TY  - CPAPER
AB  - Type I interferons (IFNs) are produced early upon virus infection and signal through the alpha/beta interferon (IFN-/) receptor(IFNAR) to induce genes that encode proteins important for limiting viral replication and directing immune responses. Toinvestigate the extent to which type I IFNs play a role in the local regulation of inflammation in the airways, we examined theirimportance in early lung responses to infection with respiratory syncytial virus (RSV). IFNAR1-deficient (IFNAR1 / ) mice displayedincreased lung viral load and weight loss during RSV infection. As expected, expression of IFN-inducible genes was markedlyreduced in the lungs of IFNAR1 /  mice. Surprisingly, we found that the levels of proinflammatory cytokines and chemokinesin the lungs of RSV-infected mice were also greatly reduced in the absence of IFNAR signaling. Furthermore, low levels ofproinflammatory cytokines were also detected in the lungs of IFNAR1 /  mice challenged with noninfectious innate immunestimuli such as selected Toll-like receptor (TLR) agonists. Finally, recombinant IFN- was sufficient to potentiate the productionof inflammatory mediators in the lungs of wild-type mice challenged with innate immune stimuli. Thus, in addition to itswell-known role in antiviral resistance, type I IFN receptor signaling acts as a central driver of early proinflammatory responsesin the lung. Inhibiting the effects of type I IFNs may therefore be useful in dampening inflammation in lung diseases characterizedby enhanced inflammatory cytokine production.
AU  - Goritzka,M
AU  - Durant,LR
AU  - Pereira,C
AU  - Salek-Ardakani,S
AU  - Openshaw,P
AU  - Johansson,C
EP  - 6136
PB  - Wiley
PY  - 2014///
SN  - 0019-2805
SP  - 6128
TI  - Interferon-a/b  receptor signalling is amplifying early proinflammatory cytokine production in the lung during Respiratory Syncytial Virus (RSV) infection
UR  - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000327487700209&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
ER  -
Download
Faculty of MedicineNational Heart and Lung Institute
NIHR HPRU Important links

Important links

General enquiries

NIHR HPRU in Respiratory Infections

Dr Victor Phillip Dahdaleh (VPD) Building
Level 5, Office 586
Imperial College London
Hammersmith Campus
Du Cane Road
London, W12 0NN

s.evetts@imperial.ac.uk